Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F13KG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,086
Award facts
- Contract value 100% obligated
- $13,086.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,086.40 delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count unit dose packages) on December 19, 2025, with a completion date of December 22, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be fulfilled at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs.
AmerisourceBergen Drug Corp, a prominent healthcare solutions provider registered in the System for Award Management, holds a critical role in supplying pharmaceutical products to military and veteran healthcare systems through its DLA contract vehicle. The SPE2DX IDC functions as a comprehensive global pharmaceutical support program, enabling the distributor to supply a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare operations worldwide. This delivery order for RINVOQ ER—a rheumatoid arthritis treatment—exemplifies the company's extensive pharmaceutical portfolio and its capacity to fulfill federal medical supply requirements through open competition without set-aside provisions.
Quick answers
Who was awarded contract SPE2DR26F13KG?
SPE2DR26F13KG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26F13KG worth?
The government has obligated $13,086 on SPE2DR26F13KG.
Is contract SPE2DR26F13KG an order under another contract?
Yes. SPE2DR26F13KG is a delivery order under SPE2DR25D1110, an indefinite delivery contract.
Was contract SPE2DR26F13KG competed?
The extent of competition for SPE2DR26F13KG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award